Drug
Acarbose clinical trials
Also written Precose.
- studies test it
- 54
- open now
- 0
- in phase 3
- 11
- first study started
- 1998
How studies write it
Studies that test it under each name
Name
Brand
Studies by the year they started
53 studies that test it; most in 2007 (5)
| Year | Studies |
|---|---|
| 1998 | 1 |
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 5 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 5 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 2 |
| 2022 | 2 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 7
- Phase 2
- 6
- Phase 3
- 11
- Phase 4
- 25
- No phase
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 13 · Other 41
Bayer (7) · RenJi Hospital (2) · Nanjing First Hospital, Nanjing Medical University (2) · Taichung Veterans General Hospital (2) · GWT-TUD GmbH (2) · Shifa International Hospital (1) · AgelessRx (1) · Oregon State University (1)
Often tested with
Tested in the same studies.
Metformin (11) · Sitagliptin (4) · Repaglinide (3) · Pioglitazone (3) · Insulin Glargine (2) · Dapagliflozin (2) · Glucagon-Like Peptide-1 Receptor Agonists (1) · Insulin glulisine (1)
Studies
Open first, then newest update. How each study uses Acarbose is read from its arms, and is right about nine times in ten.
Testing it · 54
- CGM-Guided Acarbose for Painful Diabetic NeuropathyCompletedPhase 1Shifa International HospitalNCT07436585Written as Acarbose 50 mg
- Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC)WithdrawnPhase 2University of Alabama at BirminghamNCT05487859Written as Acarbose Tablets
- Study of Acarbose in LongevityTerminatedPhase 2Montefiore Medical CenterNCT02953093Written as Acarbose
- Acarbose and Prandial Insulin for the Treatment of Gestational Diabetes Mellitus.TerminatedPhase 3Assistance Publique - Hôpitaux de ParisNCT03380546Written as Acarbose
- The Efficacy and Tolerability of Acarbose in Healthy IndividualsCompletedPhase 4AgelessRxNCT05542849Written as Acarbose Tablets 50mg
- Human Oral Detection of Glucose OlygomersCompletedPhase 4Oregon State UniversityNCT02589353Written as Acarbose
- Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 DiabetesStatus unknownPhase 3Nanjing First Hospital, Nanjing Medical UniversityNCT05629806Written as Acarbose
- Research of Intensive Lifestyle Intervention for PCOS Patients With IGTCompletedNot applicableRenJi HospitalNCT02446834Written as Acarbose
- Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin TherapyCompletedPhase 4SanofiNCT03359837Written as Acarbose
- Comparison of the FGM Profiles in Patients of Type 2 Diabetes Treated With Sitagliptin and AcarboseCompletedNot applicableNanjing First Hospital, Nanjing Medical UniversityNCT05035849Written as sitagliptin and acarbose
- Acarbose and Older Adults With Postprandial HypotensionCompletedPhase 2Kenneth MaddenNCT01914133Written as Acarbose
- Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM PatientsCompletedPhase 4The Catholic University of KoreaNCT01490918Written as Acarbose
- Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure PatientsCompletedPhase 3BayerNCT03349684Written as Acarbose
- Remission Evaluation of Metabolic Interventions in Type 2 Diabetes (REMIT Pilot Trial)CompletedPhase 4Population Health Research InstituteNCT01181674Written as acarbose
- Bioequivalence Study for Acarbose/Metformin FDCCompletedPhase 1BayerNCT04065581Written as Acarbose/Metformin FDC(BAY81-9783)
- Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small IntestinesCompletedNot applicableUniversity Hospital, Gentofte, CopenhagenNCT03241303Written as Acarbose
- Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic AgentsStatus unknownPhase 4Peking Union Medical College HospitalNCT04287387Written as Acarbose Tablets
- Effects of Liraglutid, Dapagliflozin and Acarbose on the Cognitive Function, Olfactory Function, and Odor-induced Brain Activation in Overweight/Obese T2DM Patients Controlled Inadequately With Metformin Monotherapy.Status unknownNot applicableThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolNCT03961659Written as Acarbose
- Acarbose Anti-aging Effects in Geriatric Subjects (Substudy B & C)CompletedPhase 2The University of Texas Health Science Center at San AntonioNCT02865499Written as acarbose
- A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313)CompletedPhase 4Merck Sharp & Dohme LLCNCT01709305Written as Acarbose
See all 54 studies that test Acarbose →
Given in every arm · 4 — Acarbose is usual care beside what is tested
- Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)CompletedPhase 4SanofiNCT02836704Written as acarbose
- A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)TerminatedPhase 4Eli Lilly and CompanyNCT02072096Written as Acarbose
- Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130)CompletedPhase 3Merck Sharp & Dohme LLCNCT01177384Written as Acarbose
- Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 DiabetesCompletedNot applicableServices Hospital, LahoreNCT01624116Written as Acarbose
As the comparator · 15 — what is tested is compared with Acarbose
- A Multicenter, Randomized, Open-Label, Parallel-Controlled Clinical Study Comparing the Efficacy and Safety of Cofrogliptin Versus Acarbose in Drug-Naïve Patients With Type 2 DiabetesNot yet recruitingNot applicableHaisco Pharmaceutical Group Co., Ltd.NCT07122102Written as Acarbose
- A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes MellitusTerminatedPhase 3Astellas Pharma IncNCT01514838Written as acarbose
- Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug NaiveCompletedPhase 4SanofiNCT03794336Written as Acarbose
- Role of Insulin Action and Free Fatty Acids in Hyperandrogenism of Women With Polycystic Ovary SyndromeCompletedNot applicableJean-Patrice BaillargeonNCT01019356Written as Acarbose
- A Phase IV Study in Drug-Naive Patients With T2DM in ChinaTerminatedPhase 4AstraZenecaNCT03344341Written as Acarbose
- Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 DiabetesCompletedPhase 4TakedaNCT02049814Written as Acarbose
- Effects of a Dipeptidyl Peptidase-4 Inhibitor Sitagliptininsulin on the Progression of Coronary Atherosclerosis in Patients With Type 2 DiabetesStatus unknownPhase 4Chinese PLA General HospitalNCT03602638Written as Acarbose
- 24-Week, Multicenter, Randomized, Parallel-group, Open-label, Active Controlled Phase IV Study to Assess the Efficacy, Safety and Tolerability of Saxagliptin Compared With Acarbose When in Combination With Metformin in Patients With T2D Inadequately Controlled With Metformin MonotherapyCompletedPhase 4AstraZenecaNCT02243176Written as Acarbose
- Efficacy and Safety of Mitiglinide vs Acarbose in Patients With Type 2 Diabetes MellitusCompletedPhase 4Zhongda HospitalNCT02143765Written as Acarbose
- Effect of Gemigliptin or Acarbose on Endothelial Function in Type 2 DM PatientsStatus unknownPhase 4Seoul National University HospitalNCT02500329Written as Acarbose
- Effects of Quercetin on Blood Sugar and Blood Vessel Function in Type 2 Diabetes.CompletedPhase 2Bastyr UniversityNCT01839344Written as Acarbose
- Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin SecretionCompletedPhase 4Novartis PharmaceuticalsNCT01030952Written as Acarbose
- Effects of Nateglinide vs Acarbose on Postprandial Glucose Fluctuation, Dyslipidemia, and Inflammatory FactorsCompletedPhase 4Novartis PharmaceuticalsNCT00928889Written as Acarbose 50 mg
- Thiazolidinedione (TZD) on the Diabetic Retinopathy and NephropathyStatus unknownPhase 4Taipei Veterans General Hospital, TaiwanNCT01175486Written as Acarbose
- Exercise and Acarbose in Type 2 DiabetesCompletedPhase 4Karolinska InstitutetNCT01244971Written as Acarbose
Codes
What other systems call Acarbose · ClinicalTrials.gg INT008778
- MeSH (NLM) D020909AcarboseConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) T58MSI464GACARBOSEConfirmed FDA, NLM, Wikidata
- RxNorm 16681Confirmed FDA, Wikidata
- Wikidata Q125699761AcarboseConfirmed FDA, NLM, Wikidata
- Wikidata Q338005acarboseConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C983AcarboseConfirmed FDA, Wikidata
- DrugBank DB00284One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D020909 | Acarbose | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | T58MSI464G | ACARBOSE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 16681 | — | Confirmed FDA, Wikidata |
| Wikidata | Q125699761 | Acarbose | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q338005 | acarbose | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C983 | Acarbose | Confirmed FDA, Wikidata |
| DrugBank | DB00284 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.